Verition Fund Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.5M | Buy |
138,297
+55,121
| +66% | +$4.57M | 0.05% | 406 |
|
|
2025
Q1 | $6.75M | Hold |
83,176
| – | – | 0.03% | 608 |
|
|
2024
Q4 | $7.49M | Sell |
83,176
-15,116
| -15% | -$1.36M | 0.03% | 560 |
|
|
2024
Q3 | $9.71M | Buy |
98,292
+15,116
| +18% | +$1.49M | 0.05% | 360 |
|
|
2024
Q2 | $7.71M | Buy |
83,176
+78,871
| +1,832% | +$7.31M | 0.04% | 404 |
|
|
2024
Q1 | $409K | Buy |
+4,305
| New | +$409K | ﹤0.01% | 1557 |
|
|
2023
Q4 | – | Sell |
-83,176
| Closed | -$6.07M | – | 2251 |
|
|
2023
Q3 | $6.07M | Hold |
83,176
| – | – | 0.07% | 321 |
|
|
2023
Q2 | $6.92M | Hold |
83,176
| – | – | 0.09% | 256 |
|
|
2023
Q1 | $6.34M | Hold |
83,176
| – | – | 0.09% | 268 |
|
|
2022
Q4 | $6.9M | Sell |
83,176
-15,000
| -15% | -$1.25M | 0.11% | 197 |
|
|
2022
Q3 | $7.79M | Hold |
98,176
| – | – | 0.09% | 234 |
|
|
2022
Q2 | $7.29M | Buy |
98,176
+58,385
| +147% | +$4.34M | 0.14% | 157 |
|
|
2022
Q1 | $3.58M | Buy |
39,791
+20,520
| +106% | +$1.84M | 0.04% | 402 |
|
|
2021
Q4 | $2.16M | Buy |
19,271
+5,470
| +40% | +$613K | 0.02% | 566 |
|
|
2021
Q3 | $1.74M | Buy |
+13,801
| New | +$1.74M | 0.02% | 528 |
|
|
2021
Q2 | – | Sell |
-25,000
| Closed | -$3.39M | – | 2031 |
|
|
2021
Q1 | $3.39M | Buy |
+25,000
| New | +$3.39M | 0.04% | 213 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1315 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1308 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1085 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 988 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 1246 |
|
|
2014
Q1 | – | Sell |
-101,382
| Closed | -$4.4M | – | 627 |
|
|
2013
Q4 | $4.4M | Buy |
101,382
+85,917
| +556% | +$3.73M | 0.78% | 17 |
|
|
2013
Q3 | $666K | Sell |
15,465
-60,795
| -80% | -$2.62M | 0.1% | 139 |
|
|
2013
Q2 | $2.65M | Buy |
+76,260
| New | +$2.65M | 0.49% | 28 |
|